Negro-Vilar A - Search Results

1

Phase III placebo-controlled trial of denileukin diftitox for patients with cutaneous T-cell lymphoma.

Prince HM, Duvic M, Martin A, Sterry W, Assaf C, Sun Y, Straus D, Acosta M, Negro-Vilar A. Prince HM, et al. Among authors: negro vilar a. J Clin Oncol. 2010 Apr 10;28(11):1870-7. doi: 10.1200/JCO.2009.26.2386. Epub 2010 Mar 8. J Clin Oncol. 2010. PMID: 20212249 Clinical Trial.

2

Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.

Ramlau R, Zatloukal P, Jassem J, Schwarzenberger P, Orlov SV, Gottfried M, Pereira JR, Temperley G, Negro-Vilar R, Rahal S, Zhang JK, Negro-Vilar A, Dziewanowska ZE. Ramlau R, et al. Among authors: negro vilar a. J Clin Oncol. 2008 Apr 10;26(11):1886-92. doi: 10.1200/JCO.2007.12.2614. J Clin Oncol. 2008. PMID: 18398154 Clinical Trial.

3

Phase III trial comparing carboplatin, paclitaxel, and bexarotene with carboplatin and paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT II.

Blumenschein GR Jr, Khuri FR, von Pawel J, Gatzemeier U, Miller WH Jr, Jotte RM, Le Treut J, Sun SL, Zhang JK, Dziewanowska ZE, Negro-Vilar A. Blumenschein GR Jr, et al. Among authors: negro vilar a. J Clin Oncol. 2008 Apr 10;26(11):1879-85. doi: 10.1200/JCO.2007.12.2689. J Clin Oncol. 2008. PMID: 18398153 Clinical Trial.

4

Identification of polymorphisms associated with hypertriglyceridemia and prolonged survival induced by bexarotene in treating non-small cell lung cancer.

Luo W, Schork NJ, Marschke KB, Ng SC, Hermann TW, Zhang J, Sanders JM, Tooker P, Malo N, Zapala MA, Dziewanowska ZE, Negro-Vilar A, Meglasson MD. Luo W, et al. Among authors: negro vilar a. Anticancer Res. 2011 Jun;31(6):2303-11. Anticancer Res. 2011. PMID: 21737656

5

A selective retinoid X receptor agonist bexarotene (Targretin) prevents and overcomes acquired paclitaxel (Taxol) resistance in human non-small cell lung cancer.

Yen WC, Corpuz MR, Prudente RY, Cooke TA, Bissonnette RP, Negro-Vilar A, Lamph WW. Yen WC, et al. Clin Cancer Res. 2004 Dec 15;10(24):8656-64. doi: 10.1158/1078-0432.CCR-04-0979. Clin Cancer Res. 2004. PMID: 15623650

6

A proof-of-principle clinical trial of bexarotene in patients with non-small cell lung cancer.

Dragnev KH, Petty WJ, Shah SJ, Lewis LD, Black CC, Memoli V, Nugent WC, Hermann T, Negro-Vilar A, Rigas JR, Dmitrovsky E. Dragnev KH, et al. Clin Cancer Res. 2007 Mar 15;13(6):1794-800. doi: 10.1158/1078-0432.CCR-06-1836. Clin Cancer Res. 2007. PMID: 17363535 Clinical Trial.

7

Sleep improves when patients with chronic OA pain are managed with morning dosing of once a day extended-release morphine sulfate (AVINZA): findings from a pilot study.

Rosenthal M, Moore P, Groves E, Iwan T, Schlosser LG, Dziewanowska Z, Negro-Vilar A. Rosenthal M, et al. Among authors: negro vilar a. J Opioid Manag. 2007 May-Jun;3(3):145-54. doi: 10.5055/jom.2007.0052. J Opioid Manag. 2007. PMID: 18027540 Clinical Trial.

8

The retinoid X receptor agonist bexarotene (Targretin) synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cells.

Hermann TW, Yen WC, Tooker P, Fan B, Roegner K, Negro-Vilar A, Lamph WW, Bissonnette RP. Hermann TW, et al. Lung Cancer. 2005 Oct;50(1):9-18. doi: 10.1016/j.lungcan.2005.05.008. Lung Cancer. 2005. PMID: 15993980

9

Bexarotene (LGD1069, Targretin), a selective retinoid X receptor agonist, prevents and reverses gemcitabine resistance in NSCLC cells by modulating gene amplification.

Tooker P, Yen WC, Ng SC, Negro-Vilar A, Hermann TW. Tooker P, et al. Cancer Res. 2007 May 1;67(9):4425-33. doi: 10.1158/0008-5472.CAN-06-4495. Cancer Res. 2007. PMID: 17483357

10

A selective retinoid X receptor agonist bexarotene (LGD1069, targretin) inhibits angiogenesis and metastasis in solid tumours.

Yen WC, Prudente RY, Corpuz MR, Negro-Vilar A, Lamph WW. Yen WC, et al. Br J Cancer. 2006 Mar 13;94(5):654-60. doi: 10.1038/sj.bjc.6602995. Br J Cancer. 2006. PMID: 16495926 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

211 results

Search Page